Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Sirtuin 6 (SIRT6) mRNA 3'-untranslated region (3'-UTR) is a critical regulatory segment of the SIRT6 transcript that governs the stability and translation efficiency of the SIRT6 protein (PMID: 21655084). SIRT6 itself is a member of the sirtuin family of NAD+-dependent deacetylases and is involved in essential biological processes such as DNA repair, telomere maintenance, glucose metabolism, and longevity (PMID: 22367541). The 3'-UTR contains binding sites for various microRNAs (miRNAs) and RNA-binding proteins, which can suppress SIRT6 expression under specific physiological or pathological conditions (PMID: 24631215). For instance, miR-33 and miR-34a have been shown to target this region, leading to reduced SIRT6 levels and contributing to metabolic dysfunction or cellular senescence (PMID: 21655084, PMID: 24631215). Targeting the SIRT6 mRNA 3'-UTR with antisense oligonucleotides or miRNA mimics/antagomirs represents a therapeutic strategy to modulate SIRT6 levels in diseases like cancer, where SIRT6 can act as either a tumor suppressor or promoter depending on the context (PMID: 23245941). Furthermore, the 3'-UTR's role in post-transcriptional regulation makes it a focal point for research into aging and age-related diseases. Therapeutic interventions aiming to stabilize SIRT6 mRNA by blocking miRNA binding sites are currently being explored to enhance its protective effects. Overall, the SIRT6 mRNA 3'-UTR serves as a pivotal node for controlling the dosage of this multi-functional protein in human health and disease.
Modulation of SIRT6 protein expression through RNA interference or by blocking the binding of regulatory microRNAs and RNA-binding proteins to the 3'-UTR.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sirtuin 6 mRNA 3'-untranslated region (SIRT6 mRNA 3'-UTR) (SIRT6 mRNA 3'-UTR).